Korean Journal of Radiology (ISSN: 1229-6929, E-ISSN: 2005-8330), published by the Korean Society of Radiology, stands as a leading international platform for the dissemination of high-quality research and advancements in the fields of radiology, nuclear medicine, and imaging. With a remarkable impact factor and ranked in the Q1 quadrant in its category, this journal showcases cutting-edge studies, clinical investigations, and comprehensive reviews that significantly contribute to the understanding and practice of medical imaging. Researchers, clinicians, and students alike will find the journal an invaluable resource, featuring innovative methodologies, case studies, and essential updates in imaging technology. Since its inception in 2000 and continuing through 2024, the Korean Journal of Radiology remains dedicated to promoting excellence and fostering collaborative research within the global radiology community, underscoring the importance of imaging in modern medicine.

CLINICAL NUCLEAR MEDICINE is a premier journal dedicated to the field of nuclear medicine, published by Lippincott Williams & Wilkins. With a history of excellence since its inception in 1978, the journal serves as a vital resource for researchers, healthcare professionals, and students seeking to deepen their understanding of this rapidly evolving discipline. The journal holds a commendable Q2 ranking in both Medicine (miscellaneous) and Radiology, Nuclear Medicine and Imaging, reflecting its significant impact on advancing clinical practices and research. While currently not offered as an open-access publication, CLINICAL NUCLEAR MEDICINE ensures rigorous peer review and high-quality publications, contributing to the broad dissemination of cutting-edge studies and reviews. With its comprehensive scope encompassing both diagnostic and therapeutic nuclear medicine applications, researchers around the globe turn to this journal to stay informed and inspire innovations in patient care for the years leading up to 2024 and beyond.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging, published by Edizioni Minerva Medica in Italy, serves as a pivotal platform for researchers and practitioners in the fields of Nuclear Medicine and Molecular Imaging. With an ISSN of 1824-4785 and an E-ISSN of 1827-1936, this journal boasts a respectable impact factor and is positioned in the Q3 quartile of the Radiology, Nuclear Medicine and Imaging category, based on the latest 2023 evaluations. As the journal continues to converge from its inception in 2004 to its anticipated expansions through 2024, it aims to disseminate high-quality, peer-reviewed articles that advance the frontier of imaging technologies and their applications in clinical practice. Researchers, professionals, and students are encouraged to contribute to its diverse scope, which encompasses innovative research, clinical findings, and reviews that encapsulate cutting-edge advancements in the field, highlighting its importance as an essential resource for knowledge and collaboration.

Imaging, published by AKADEMIAI KIADO ZRT, is an esteemed open-access journal dedicated to the field of medical imaging, established in 2020. With an E-ISSN of 2732-0960 and based in Budapest, Hungary, this journal provides a vital platform for the dissemination of cutting-edge research and advancements in imaging techniques, especially in the realms of radiology, nuclear medicine, and ultrasound technology. While currently positioned in the Q4 category across multiple medical specialties, the journal continues to strive for improvements in visibility and impact, contributing to the evolving discourse in medical imaging. The journal aims to facilitate an inclusive and collaborative environment for researchers, professionals, and students, inviting them to share their findings and insights to enhance the field's development. With open-access availability since its inception, Imaging ensures free and easy access to its content, fostering a greater understanding and appreciation of innovative imaging practices worldwide.

Revista Española de Medicina Nuclear e Imagen Molecular, published by Elsevier España SLU, stands as a vital resource in the field of Radiology, Nuclear Medicine, and Molecular Imaging. With an ISSN of 2253-654X, this journal is committed to disseminating high-quality research and advancements in clinical practices, aiming to bridge the gap between theoretical research and application in healthcare. Operating since 2012, it features a robust archive of peer-reviewed articles and case studies, although it currently holds a Q4 ranking in the Scopus category, indicating significant potential for growth and influence within the academic community. The journal is indexed in Scopus, with a rank of 255 out of 333, placing it in the 23rd percentile, which underlines the need for increased contributions from researchers eager to enhance its standing. While it is not an open-access journal, its availability through libraries and institutions ensures that a wide audience can access critical findings and innovations in the rapidly evolving field of nuclear medicine. As we look towards the convergence period from 2012 to 2024, Revista Española de Medicina Nuclear e Imagen Molecular aspires to fortify its role as a cornerstone for collaboration and advancement in nuclear imaging and radiology.

CANCER IMAGING, published by BMC, stands as a leading open-access journal in the realms of oncology and medical imaging, significantly contributing to the advancement of cancer research since its inception in 2000. With an impressive impact across multiple domains—most notably ranking Q1 in prestigious categories such as Medicine (miscellaneous), Oncology, and Radiology—this journal ensures high visibility and influence within the academic community. As of 2023, it is recognized in various Scopus rankings, securing top positions in the fields of Radiology, Nuclear Medicine, and Imaging, alongside Radiological and Ultrasound Technology. The journal's commitment to open-access publication, adopted in 2014, enhances accessibility for researchers, healthcare professionals, and students alike, fostering an inclusive environment for sharing critical advancements and innovative methodologies in cancer imaging. Set in the vibrant landscape of the United Kingdom, CANCER IMAGING continues to play a vital role in elucidating the complexities of cancer diagnostics and treatment, establishing itself as an essential resource for those pursuing excellence in cancer care and research.

Welcome to Seminars in Nuclear Medicine, a prestigious journal published by W B Saunders Co-Elsevier Inc that has been at the forefront of the field since its inception in 1971. This journal serves as a dedicated forum for researchers, healthcare professionals, and students specializing in the rapidly evolving areas of radiology and nuclear medicine. With an impressive ranking of #29 out of 333 in the Scopus category, drawing an esteemed 91st percentile, it holds a distinguished Q1 category status, highlighting its critical role in disseminating high-quality research and clinical practices. Although it does not operate as an Open Access publication, Seminars in Nuclear Medicine remains a vital resource, featuring comprehensive reviews and insightful articles that inform the medical community about the latest advancements and applications within nuclear imaging. This journal not only enhances knowledge but also encourages collaboration among professionals dedicated to improving patient outcomes through innovative nuclear medicine techniques.

INVESTIGATIVE RADIOLOGY, published by Lippincott Williams & Wilkins, is a premier peer-reviewed journal dedicated to disseminating innovative research in the fields of radiology, nuclear medicine, and imaging. With a notable impact factor underscored by its impressive ranking—10th out of 333 in its category, positioning it within the 97th percentile—this journal serves as a vital resource for researchers, professionals, and students eager to stay at the forefront of advancements from 1966 to 2024. Although it does not offer open access, the high-quality studies and reviews found within its pages contribute significantly to the understanding and application of modern imaging techniques. Recognized for its Q1 status in both miscellaneous medicine and radiology specializations, INVESTIGATIVE RADIOLOGY continues to play an essential role in shaping the future of diagnostic and therapeutic imaging.

EJNMMI Research, a prominent journal published by Springer, plays a pivotal role in advancing the fields of radiology, nuclear medicine, and imaging. With an impact factor that reflects its strong standing—ranking in the top 22% of its category (Q1 as of 2023)—this open-access journal offers researchers, professionals, and students unparalleled access to innovative research and developments in the field since its inception in 2011. Based in Germany, EJNMMI Research fosters global collaboration by ensuring that cutting-edge findings are freely accessible, thereby accelerating scientific discovery and application. With an emphasis on high-quality, peer-reviewed articles, it serves as an essential resource for those seeking to stay at the forefront of nuclear medicine and imaging. By bridging theoretical insights with practical applications, the journal not only influences academic discourse but also supports ongoing advancements in clinical practices.

NUCLEAR MEDICINE REVIEW is a distinguished journal in the field of radiology, nuclear medicine, and imaging, published by VIA MEDICA in Poland. Since its transition to an open access format in 1999, this journal has been dedicated to promoting the dissemination of knowledge and research findings across a global audience. With a focus on innovative approaches and advancements in nuclear medicine, it aims to serve as a key resource for researchers, professionals, and students who are working to further the understanding of nuclear imaging and its applications. In 2023, the journal was classified in the Q3 category within Radiology, Nuclear Medicine and Imaging, and Q4 in the broader category of Medicine (miscellaneous), highlighting its growing reputation in the academic community. As of the latest assessments, the journal has been ranked #235 out of 333 in its field according to Scopus metrics, reflecting its commitment to excellence and the relevance of its published works. The NUCLEAR MEDICINE REVIEW is a pivotal platform for those engaged in cutting-edge research, providing insights that drive the evolution of medical imaging and therapeutic techniques.